1. Home
  2. ZDAI vs JUNS Comparison

ZDAI vs JUNS Comparison

Compare ZDAI & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZDAI
  • JUNS
  • Stock Information
  • Founded
  • ZDAI 2022
  • JUNS 2015
  • Country
  • ZDAI Hong Kong
  • JUNS United States
  • Employees
  • ZDAI N/A
  • JUNS N/A
  • Industry
  • ZDAI General Bldg Contractors - Nonresidential Bldgs
  • JUNS
  • Sector
  • ZDAI Consumer Discretionary
  • JUNS
  • Exchange
  • ZDAI Nasdaq
  • JUNS NYSE
  • Market Cap
  • ZDAI 20.6M
  • JUNS 20.5M
  • IPO Year
  • ZDAI 2024
  • JUNS 2024
  • Fundamental
  • Price
  • ZDAI $0.60
  • JUNS $1.62
  • Analyst Decision
  • ZDAI
  • JUNS
  • Analyst Count
  • ZDAI 0
  • JUNS 0
  • Target Price
  • ZDAI N/A
  • JUNS N/A
  • AVG Volume (30 Days)
  • ZDAI 60.7K
  • JUNS 738.9K
  • Earning Date
  • ZDAI 08-15-2025
  • JUNS 08-11-2025
  • Dividend Yield
  • ZDAI N/A
  • JUNS N/A
  • EPS Growth
  • ZDAI N/A
  • JUNS N/A
  • EPS
  • ZDAI N/A
  • JUNS N/A
  • Revenue
  • ZDAI $17,166,534.00
  • JUNS N/A
  • Revenue This Year
  • ZDAI N/A
  • JUNS N/A
  • Revenue Next Year
  • ZDAI N/A
  • JUNS $6,418.21
  • P/E Ratio
  • ZDAI $19.05
  • JUNS N/A
  • Revenue Growth
  • ZDAI 56.11
  • JUNS N/A
  • 52 Week Low
  • ZDAI $0.37
  • JUNS $0.51
  • 52 Week High
  • ZDAI $107.36
  • JUNS $19.51
  • Technical
  • Relative Strength Index (RSI)
  • ZDAI N/A
  • JUNS N/A
  • Support Level
  • ZDAI N/A
  • JUNS N/A
  • Resistance Level
  • ZDAI N/A
  • JUNS N/A
  • Average True Range (ATR)
  • ZDAI 0.00
  • JUNS 0.00
  • MACD
  • ZDAI 0.00
  • JUNS 0.00
  • Stochastic Oscillator
  • ZDAI 0.00
  • JUNS 0.00

About JUNS JUPITER NEUROSCIENCES INC

Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.

Share on Social Networks: